Skip to main content

What the FDA labels say about taking them together

Etravirine and rifabutin

Etravirine's FDA label of August 15, 2023 names rifabutin in its drug interactions section, and rifabutin's label names etravirine too. The etravirine label: “If INTELENCE is NOT co-administered with a protease inhibitor/ritonavir, then rifabutin at a dose of 300 mg once daily is recommended. …”

Check it at the source: the etravirine FDA label on DailyMed (effective August 15, 2023, Janssen Products LP); the rifabutin FDA label on DailyMed (effective September 1, 2026, REMEDYREPACK INC.).

What does the etravirine label say about rifabutin?

Etravirine label, drug interactions

Concomitant Drug Class/Drug Name: Antimycobacterial: rifabutin; Effect on Concentration of Etravirine or Concomitant Drug: ↓ etravirine ↓ rifabutin ↓ 25- O -desacetylrifabutin; Clinical Comment: If INTELENCE is NOT co-administered with a protease inhibitor/ritonavir, then rifabutin at a dose of 300 mg once daily is recommended. If INTELENCE is co-administered with darunavir/ritonavir, lopinavir/ritonavir or saquinavir/ritonavir, then rifabutin should not be co-administered due to the potential for significant reductions in etravirine exposure.

Source: FDA drug label (Intelence), Janssen Products LP, effective August 15, 2023 (SPL set 6a9cbc29-9f15-4b24-8d86-206b82887f3d), via openFDA; the full label on DailyMed

What does the rifabutin label say about etravirine?

Rifabutin label, drug interactions

Etravirine 800 mg twice daily for 21 days 300 mg daily on days 8 to 21 Healthy volunteers (18) No significant change in rifabutin pharmacokinetics.

Source: FDA drug label (Rifabutin), NDA050689 (Pfizer), as published by REMEDYREPACK INC., effective September 1, 2026 (SPL set 25a60937-cbbe-4a50-994f-2ce15203f589), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

5Etravirine generic labelers
4Rifabutin generic labelers
EtravirineRifabutin
Labeled forHIVn/a
Boxed warningNoNo
Pharmacy cost (NADAC)$9.94 per tablet 200 mg tablet$8.14 per capsule 150 mg capsule
Shortage nowA presentation being discontinuedNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?